Skip to content
Riskpilot
← Back to search
Sign in
Get full access
AS 1 AF 25. APRIL 2014 A.M.B.A.
ABA
In liquidation
CVR 25492242
Langelinie Allé 35, 2100
København Ø
Retail sale of pharmaceutical products
· NACE 4773
Est. 2000
— employees
Watchlist
Share
Denmark
/
Companies
/
Retail sale of pharmaceutical products
/
AS 1 AF 25. APRIL 2014 A.M.B.A.
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
2M
4M
6M
8M
6M
2012
7M
2013
EBITDA
DKK millions
0M
1M
2M
3M
3M
3M
2012
3M
2013
Income statement
DKK thousands
Item
2012
2013
Revenue
5.811
6.844
Staff expenses
-3.070
-3.534
EBITDA
2.741
3.310
Depreciation & amort.
-2.581
-3.265
EBIT
160
44
Net financials
-88
-44
Profit before tax
72
0
Tax
72
0
Net profit
0
0
Balance sheet
DKK thousands
Item
2012
2013
Total assets
17.917
5.443
Equity
275
270
Long-term debt
0
0
Short-term debt
17.552
5.173
Total debt
17.552
5.173
Financial ratios
5-year trend
EBITDA margin
48.4%
This company
15.8%
Market median
+206% vs market
2012
2013
Equity ratio
5.0%
This company
38.2%
Market median
-87% vs market
2012
2013
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
2012
2013
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
2012
2013
Asset turnover
1.26×
This company
1.12×
Market median
+12% vs market
2012
2013
Debt / equity
19.16×
This company
0.62×
Market median
-2990% vs market
2012
2013
Annual reports & filings
Annual report 2013
Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
View
PDF
Annual report 2012
Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
View
PDF
More on AS 1 AF 25. APRIL 2014 A.M.B.A.
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
